AIA
GSK icon

Avalon Investment & Advisory’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,805
Closed -$671K 359
2021
Q1
$671K Sell
18,805
-395,456
-95% -$14.1M 0.02% 265
2020
Q4
$15.2M Sell
414,261
-142,983
-26% -$5.26M 0.31% 101
2020
Q3
$21M Sell
557,244
-32,488
-6% -$1.22M 0.47% 65
2020
Q2
$24.1M Sell
589,732
-41,880
-7% -$1.71M 0.55% 55
2020
Q1
$23.9M Buy
631,612
+48,760
+8% +$1.85M 0.61% 49
2019
Q4
$27.4M Buy
582,852
+13,888
+2% +$653K 0.56% 55
2019
Q3
$24.3M Buy
568,964
+10,219
+2% +$436K 0.54% 61
2019
Q2
$22.4M Sell
558,745
-3,550
-0.6% -$142K 0.5% 64
2019
Q1
$23.5M Buy
562,295
+26,098
+5% +$1.09M 0.53% 57
2018
Q4
$20.5M Buy
536,197
+6,966
+1% +$266K 0.53% 53
2018
Q3
$21.3M Buy
529,231
+77,180
+17% +$3.1M 0.6% 50
2018
Q2
$18.2M Buy
452,051
+412,153
+1,033% +$16.6M 0.54% 69
2018
Q1
$1.56M Buy
39,898
+5,143
+15% +$201K 0.05% 229
2017
Q4
$1.23M Sell
34,755
-312,865
-90% -$11.1M 0.04% 239
2017
Q3
$14.1M Buy
347,620
+9,863
+3% +$400K 0.45% 79
2017
Q2
$14.6M Buy
337,757
+1,089
+0.3% +$47K 0.48% 69
2017
Q1
$14.2M Sell
336,668
-15,888
-5% -$670K 0.49% 70
2016
Q4
$13.6M Sell
352,556
-303,368
-46% -$11.7M 0.49% 67
2016
Q3
$28.3M Buy
655,924
+80,604
+14% +$3.48M 1.06% 26
2016
Q2
$24.9M Buy
575,320
+546,467
+1,894% +$23.7M 0.96% 35
2016
Q1
$1.17M Buy
28,853
+14,910
+107% +$605K 0.05% 147
2015
Q4
$563K Buy
13,943
+3
+0% +$121 0.02% 195
2015
Q3
$536K Sell
13,940
-1,498
-10% -$57.6K 0.02% 196
2015
Q2
$643K Buy
15,438
+3,073
+25% +$128K 0.03% 177
2015
Q1
$571K Sell
12,365
-672
-5% -$31K 0.02% 154
2014
Q4
$557K Buy
13,037
+138
+1% +$5.9K 0.03% 137
2014
Q3
$593K Sell
12,899
-370,854
-97% -$17M 0.03% 141
2014
Q2
$20.5M Buy
383,753
+134,257
+54% +$7.18M 1.04% 27
2014
Q1
$13.3M Buy
249,496
+2,319
+0.9% +$124K 0.74% 46
2013
Q4
$13.2M Buy
247,177
+4,071
+2% +$217K 0.74% 47
2013
Q3
$12.2M Buy
243,106
+1,245
+0.5% +$62.5K 0.79% 43
2013
Q2
$12.1M Buy
+241,861
New +$12.1M 0.72% 47